Schally AV - Search Results

1

Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238.

Lasfer M, Vadrot N, Schally AV, Nagy A, Halmos G, Pessayre D, Feldmann G, Reyl-Desmars FJ. Lasfer M, et al. Among authors: schally av. J Hepatol. 2005 Feb;42(2):230-7. doi: 10.1016/j.jhep.2004.10.014. J Hepatol. 2005. PMID: 15664249

2

Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238.

Plonowski A, Schally AV, Nagy A, Sun B, Halmos G. Plonowski A, et al. Among authors: schally av. Int J Oncol. 2002 Feb;20(2):397-402. Int J Oncol. 2002. PMID: 11788908

3

Effective treatment of H838 human non-small cell lung carcinoma with a targeted cytotoxic somatostatin analog, AN-238.

Szereday Z, Schally AV, Szepeshazi K, Bajo AM, Hebert F, Halmos G, Nagy A. Szereday Z, et al. Among authors: schally av. Int J Oncol. 2003 May;22(5):1141-6. Int J Oncol. 2003. PMID: 12684683

4

Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.

Bajo AM, Schally AV, Halmos G, Nagy A. Bajo AM, et al. Among authors: schally av. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3742-8. Clin Cancer Res. 2003. PMID: 14506166

5

Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas.

Szepeshazi K, Schally AV, Nagy A, Wagner BW, Bajo AM, Halmos G. Szepeshazi K, et al. Among authors: schally av. Cancer. 2003 Oct 1;98(7):1401-10. doi: 10.1002/cncr.11649. Cancer. 2003. PMID: 14508826 Free article.

6

Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238.

Keller G, Engel JB, Schally AV, Nagy A, Hammann B, Halmos G. Keller G, et al. Among authors: schally av. Int J Cancer. 2005 May 1;114(5):831-5. doi: 10.1002/ijc.20806. Int J Cancer. 2005. PMID: 15609311

7

Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.

Engel JB, Keller G, Schally AV, Halmos G, Hammann B, Nagy A. Engel JB, et al. Among authors: schally av. Clin Cancer Res. 2005 Mar 15;11(6):2408-15. doi: 10.1158/1078-0432.CCR-04-1670. Clin Cancer Res. 2005. PMID: 15788692

8

Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.

Engel JB, Keller G, Schally AV, Nagy A, Chism DD, Halmos G. Engel JB, et al. Among authors: schally av. Fertil Steril. 2005 Apr;83 Suppl 1:1125-33. doi: 10.1016/j.fertnstert.2004.10.042. Fertil Steril. 2005. PMID: 15831285 Free article.

9

Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers.

Stangelberger A, Schally AV, Letsch M, Szepeshazi K, Nagy A, Halmos G, Kanashiro CA, Corey E, Vessella R. Stangelberger A, et al. Among authors: schally av. Int J Cancer. 2006 Jan 1;118(1):222-9. doi: 10.1002/ijc.21292. Int J Cancer. 2006. PMID: 16003723

10

Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1.

Engel JB, Schally AV, Halmos G, Baker B, Nagy A, Keller G. Engel JB, et al. Among authors: schally av. Cancer. 2005 Sep 15;104(6):1312-21. doi: 10.1002/cncr.21327. Cancer. 2005. PMID: 16047355 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,459 results

Search Page

Filters